Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Isatuximab, lenalidomide, dexamethasone and bortezomib in... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial
0
Authors
Xavier Leleu
59 more
Xavier Leleu
•
Marie‐Lorraine Chrétien
57 more
•
Thierry Facon
Published
June 3, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Gastroenterology
Show all topics
DOI
10.1038/s41591-024-03050-2
License
CC-BY
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Nature Medicine
Topics
Medicine
Cancer Oncology
Internal Medicine
Hematology
Gastroenterology
Show all topics
DOI
10.1038/s41591-024-03050-2
License
CC-BY
Other Formats
PDF
